Cc-5013


Combined with:

Allopurinol
Dexamethasone

Indications and Reactions:

Role Indications Reactions
Primary
Multiple Myeloma 26.3%
Drug Use For Unknown Indication 15.3%
Prophylaxis 10.3%
Product Used For Unknown Indication 8.5%
Hypertension 7.3%
Thrombosis Prophylaxis 6.4%
Pain 4.8%
Plasma Cell Myeloma 3.4%
Constipation 2.8%
Diabetes Mellitus 1.8%
Bone Pain 1.7%
Infection Prophylaxis 1.6%
Nausea 1.6%
Back Pain 1.5%
Chronic Lymphocytic Leukaemia 1.4%
Neutropenia 1.3%
Insomnia 1.2%
Supplementation Therapy 1.0%
Hypothyroidism 0.9%
Mantle Cell Lymphoma 0.9%
Sepsis 12.2%
Thrombocytopenia 9.3%
Tumour Flare 8.7%
Pneumonia 8.5%
Myelodysplastic Syndrome 5.8%
Squamous Cell Carcinoma Of Skin 5.5%
Death 4.7%
Neutropenia 4.4%
Pulmonary Embolism 4.4%
Basal Cell Carcinoma 4.1%
Acute Myeloid Leukaemia 3.8%
General Physical Health Deterioration 3.8%
Pyrexia 3.8%
Septic Shock 3.8%
Renal Failure 3.2%
Multiple Myeloma 2.9%
Renal Failure Acute 2.9%
Tumour Lysis Syndrome 2.9%
Urinary Tract Infection 2.9%
Respiratory Failure 2.3%
Secondary
Multiple Myeloma 21.2%
Prophylaxis 11.9%
Drug Use For Unknown Indication 11.5%
Product Used For Unknown Indication 10.6%
Hypertension 7.5%
Thrombosis Prophylaxis 7.3%
Pain 4.9%
Plasma Cell Myeloma 4.4%
Chronic Lymphocytic Leukaemia 3.8%
Constipation 2.3%
Diabetes Mellitus 2.2%
Neutropenia 2.1%
Infection Prophylaxis 2.0%
Anaemia 1.6%
Atrial Fibrillation 1.3%
Bone Pain 1.2%
Insomnia 1.2%
Nausea 1.1%
Left Ventricular Dysfunction 0.9%
Infection 0.8%
Pneumonia 14.9%
Squamous Cell Carcinoma Of Skin 13.0%
Thrombocytopenia 11.1%
Neutropenia 6.9%
Basal Cell Carcinoma 6.5%
General Physical Health Deterioration 5.0%
Sepsis 5.0%
Pulmonary Embolism 4.6%
Progressive Multifocal Leukoencephalopathy 3.8%
Renal Failure Acute 3.8%
Septic Shock 3.4%
Pyrexia 3.1%
Acute Myeloid Leukaemia 2.7%
Whipple's Disease 2.7%
Hypertensive Crisis 2.3%
Lung Adenocarcinoma 2.3%
Lung Disorder 2.3%
Multiple Myeloma 2.3%
Myelodysplastic Syndrome Transformation 2.3%
Thrombosis 2.3%

Drug Data